Went in heavy on some IMMX shares yesterday in the $6 range. This could be a significant multi-day runner. One of the things I like about this stock is that it is not optionable, and it seems those are the types of biotechs that go bizerk more times than not on any sort of remotely good news.
They just got FDA fast-track approval on a potential pediatric cancer treatment.